A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration

Summary

AG-013,958 is being studied to treat patients with Age-Related Macular Degeneration. A total of 144 subjects may be enrolled in the trial. Subjects will be male or female at least 55 years of age with "wet" age-related macular degeneration.

Timeline

Start

2004-01

Primary completion

—

Completion

2006-08

Outcome

Outcome not reported

Stopped: “This study was terminated due to a lack of efficacy.”

Drugs

Indications